CN Patent

CN110603036A — 术后恶心和呕吐的补救治疗

Assigned to LXO Irish designated activity company · Expires 2019-12-20 · 6y expired

What this patent protects

氨磺必利可用于治疗患者的术后恶心和/或呕吐，其中患者已经被给予用于术后恶心和/或呕吐的预防药物，并且其中氨磺必利的剂量为7.5至15mg。

USPTO Abstract

氨磺必利可用于治疗患者的术后恶心和/或呕吐，其中患者已经被给予用于术后恶心和/或呕吐的预防药物，并且其中氨磺必利的剂量为7.5至15mg。

Drugs covered by this patent

Patent Metadata

Patent number
CN110603036A
Jurisdiction
CN
Classification
—
Expires
2019-12-20
Drug substance claim
No
Drug product claim
No
Assignee
LXO Irish designated activity company
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.